Previous studies reported that mutant KrasG12V (K-ras V12) promotes the reactive oxygen species (ROS) production in colorectal cancer cells through activation of the p38-PDPK1-PKCδ/p47phox-NOX1 cascade [51], which promotes malignant transformation [51,52]. Here, KRAS is linked to colorectal cancer.